Imatinib

Imatinib is a medication primarily used to treat certain types of cancer, particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by targeting and blocking specific proteins that cancer cells rely on to grow and multiply. By inhibiting these proteins, Imatinib helps slow down or stop the progression of the disease, leading to better outcomes for patients. Approved in the early 2000s, it represents a significant advancement in cancer treatment, often leading to improved survival rates and quality of life for those affected by these conditions.